Abstract The heterogeneous nature of osteoarthritis (OA) and the need to subtype patients is widely accepted in the field. The biomarker CRPM, a metabolite of C-reactive protein (CRP), is released to the circulation during inflammation. Blood CRPM levels have shown to be associated with disease activity and response to treatment in rheumatoid arthritis (RA). We […]
Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis.
March 22, 2021
Sci Rep